[go: up one dir, main page]

AR061560A1 - Derivados de fenil-metanona sustituidos, proceso de obtencion y medicamentos que los contienen. - Google Patents

Derivados de fenil-metanona sustituidos, proceso de obtencion y medicamentos que los contienen.

Info

Publication number
AR061560A1
AR061560A1 ARP070102729A ARP070102729A AR061560A1 AR 061560 A1 AR061560 A1 AR 061560A1 AR P070102729 A ARP070102729 A AR P070102729A AR P070102729 A ARP070102729 A AR P070102729A AR 061560 A1 AR061560 A1 AR 061560A1
Authority
AR
Argentina
Prior art keywords
lower alkyl
halogen
substituted
aryl
metanone
Prior art date
Application number
ARP070102729A
Other languages
English (en)
Inventor
Synese Jolidon
Robert Narquizian
Roger Norcross
Emmanuel Pinard
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38474053&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR061560(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR061560A1 publication Critical patent/AR061560A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Compuestos de formula general (1) en la que R1 es -OR1', heterocicloalquilo, arilo o heteroarilo, que están sin sustituir o sustituidos por alquilo inferior o halogeno; R1' es alquilo inferior, alquilo inferior sustituido por halogeno, o es -(CH2)o- cicloalquilo; R2 es -S (O)2-alquilo inferior, -S(O)2NH-alquilo inferior, NO2 o CN; R3 es arilo o heteroarilo, que están sin sustituir o sustituidos de una a tres veces por sustituyentes elegidos entre el grupo formado por alquilo inferior, alcoxi inferior, CN, NO2, halogeno, alquilo inferior sustituido por halogeno, alcoxi inferior sustituido por halogeno, arilo o sulfonamida; X es un enlace, -CH2-, -NH-, -CH2O- o -OCH2-; n es el numero 1 o 2; m es el numero 1 o 2; o es el numero 0 o 1; y a sus sales de adicion de ácido farmacéuticamente aceptables, a composiciones farmacéuticas que los contienen y a su utilizacion para el tratamiento de trastornos neurologicos y neuropsiquiátricos. Se ha encontrado que los compuestos de la formula general 1 son buenos inhibidores del transportador de la glicina 1 (GlyT-1).
ARP070102729A 2006-06-22 2007-06-21 Derivados de fenil-metanona sustituidos, proceso de obtencion y medicamentos que los contienen. AR061560A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06115916 2006-06-22

Publications (1)

Publication Number Publication Date
AR061560A1 true AR061560A1 (es) 2008-09-03

Family

ID=38474053

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070102729A AR061560A1 (es) 2006-06-22 2007-06-21 Derivados de fenil-metanona sustituidos, proceso de obtencion y medicamentos que los contienen.

Country Status (18)

Country Link
US (1) US7951836B2 (es)
EP (1) EP2035371B1 (es)
JP (1) JP4937347B2 (es)
KR (1) KR101072796B1 (es)
CN (1) CN101472886B (es)
AR (1) AR061560A1 (es)
AU (1) AU2007263083B2 (es)
BR (1) BRPI0713584A2 (es)
CA (1) CA2653355C (es)
CL (1) CL2007001802A1 (es)
ES (1) ES2406085T3 (es)
IL (1) IL195478A0 (es)
MX (1) MX2008015932A (es)
NO (1) NO20085155L (es)
RU (1) RU2437872C2 (es)
TW (1) TWI342308B (es)
WO (1) WO2007147770A2 (es)
ZA (1) ZA200810129B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101141959B (zh) * 2005-01-18 2010-12-15 弗·哈夫曼-拉罗切有限公司 作为甘氨酸转运体1(GlyT-1)抑制剂用于治疗神经学和神经精神病学障碍的2,5-二取代的苯甲酮衍生物
US9012489B2 (en) * 2011-08-03 2015-04-21 Boehringer Ingelheim International Gmbh Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament
MA39888A (fr) 2014-04-24 2017-03-01 Dart Neuroscience Cayman Ltd Composés de 2,4,5,6-tétrahydropyrrolo[3,4-c] pyrazole et 4,5,6,7-tétrahydro-2 h-pyrazolo [4,3-c] pyridine utilisés comme inhibiteurs de glyt1
WO2016073420A1 (en) * 2014-11-05 2016-05-12 Dart Neuroscience, Llc Substituted azetidinyl compounds as glyt1 inhibitors
CN116261453A (zh) 2020-08-13 2023-06-13 勃林格殷格翰国际有限公司 与思觉失调症相关的认知障碍的治疗
KR20230088761A (ko) 2020-10-13 2023-06-20 베링거 인겔하임 인터내셔날 게엠베하 재가공하는 방법
WO2025106383A1 (en) * 2023-11-17 2025-05-22 Merck Sharp & Dohme Llc Pyrrolidinyl derivatives useful as hcn1/hcn 2 modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243173B (en) * 1999-11-17 2005-11-11 Akzo Nobel Nv Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives
BRPI0413497B8 (pt) 2003-08-11 2021-05-25 Hoffmann La Roche piperazina com ou que substitui grupo fenila, e seu uso e seu processo de preparação, bem como medicamento
DE602004020674D1 (de) * 2003-09-09 2009-05-28 Hoffmann La Roche 1-benzoyl-piperazin-derivate als glycin-aufnahmehemmer zur behandlung von psychosen
US7745630B2 (en) * 2003-12-22 2010-06-29 Justin Stephen Bryans Triazolyl piperidine arginine vasopressin receptor modulators
US7485637B2 (en) * 2005-01-04 2009-02-03 Hoffmann-La Roche Inc. Benzoyl-tetrahydropiperidine derivatives
CN101141959B (zh) * 2005-01-18 2010-12-15 弗·哈夫曼-拉罗切有限公司 作为甘氨酸转运体1(GlyT-1)抑制剂用于治疗神经学和神经精神病学障碍的2,5-二取代的苯甲酮衍生物

Also Published As

Publication number Publication date
WO2007147770A2 (en) 2007-12-27
JP4937347B2 (ja) 2012-05-23
AU2007263083B2 (en) 2012-10-04
KR101072796B1 (ko) 2011-10-14
IL195478A0 (en) 2009-09-01
US7951836B2 (en) 2011-05-31
EP2035371B1 (en) 2013-03-06
RU2437872C2 (ru) 2011-12-27
CA2653355C (en) 2014-04-15
WO2007147770A3 (en) 2008-05-22
CL2007001802A1 (es) 2008-05-23
KR20090015979A (ko) 2009-02-12
MX2008015932A (es) 2009-01-13
JP2009541251A (ja) 2009-11-26
TWI342308B (en) 2011-05-21
CA2653355A1 (en) 2007-12-27
TW200808784A (en) 2008-02-16
EP2035371A2 (en) 2009-03-18
ES2406085T3 (es) 2013-06-05
AU2007263083A1 (en) 2007-12-27
BRPI0713584A2 (pt) 2012-10-23
CN101472886A (zh) 2009-07-01
CN101472886B (zh) 2011-07-13
RU2008148165A (ru) 2010-07-27
ZA200810129B (en) 2010-04-28
NO20085155L (no) 2009-01-15
US20070299071A1 (en) 2007-12-27

Similar Documents

Publication Publication Date Title
AR052866A1 (es) Fenil-metanonas monociclicas sustituidas
AR061560A1 (es) Derivados de fenil-metanona sustituidos, proceso de obtencion y medicamentos que los contienen.
MX2020000261A (es) Nuevos compuestos.
CY1110977T1 (el) Υποκατεστημενα παραγωγα ινδολης για φαρμακευτικη συνθεση για θεραπεια ασθενειων του αναπνευστικου
NI201000022A (es) Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparación, su aplicación como medicamentos, composiciones farmacéuticas y nueva utilización principalmente como inhibidores de met.
AR054035A1 (es) Derivados benzodioxano y benzodioxolano y uso de los mismos
NI201000150A (es) Nuevos derivados de carbazol, inhibidores de hsp90, composiciones que los contienen y utilización.
AR091790A1 (es) Derivados de isoquinolin-1-ona y sus usos
AR080057A1 (es) Piridinas disustituidas como anticancerigenos
UY29393A1 (es) Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones.
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
EA200501327A1 (ru) Пиримидины и триазины, ингибирующие вич репликацию
AR066972A1 (es) Derivados azapeptidicos
CY1106857T1 (el) Βενζαμιδια 4-(αμινομεθυλ)-πιπεριδινης ως 5ht4-ανταγωνιστες
UY31885A (es) Derivados de las 1, 3, 5-triazina-2, 4-diaminas-6-sustituidas-n-sustituidas y sales farmacéuticamente aceptables de los mismos, composiciones y aplicaciones.
ECSP088293A (es) Inhibidores de gamma secretasa, de sulfonamido n-cíclico puenteado
PE20140968A1 (es) Derivados de benzamida sustituida
AR053554A1 (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
UY29312A1 (es) Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones
ECSP088257A (es) Derivados de amida
AR067873A1 (es) Derivados de benzoil-piperidina como moduladores duales de receptores de 5-ht2a y de d3
AR072226A1 (es) Derivados triciclicos sustituidos, proceso e intermediario para su sintesis y su uso en medicamentos para el tratamiento de enfermedades mediadas por la actividad de gsk3beta.
AR073842A1 (es) Derivados del acido 4- dimetilaminobutirico , proceso para su preparacion , composiciones farmacéuticas y uso de los mismos
PE20090445A1 (es) Inhibidores de produccion de beta amiloide
AR081034A1 (es) Derivados de n-heteroaril tetrahidro-isoquinolina sustituidos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades del sistema nervioso central

Legal Events

Date Code Title Description
FB Suspension of granting procedure